Literature DB >> 2099119

Multispot, multianalyte, immunoassay.

R Ekins1, F Chu, E Biggart.   

Abstract

Consideration of the basic principles of immunoassay design reveals that highly sensitive assays can, in principle, be developed using amounts of "sensor" antibody far smaller than are currently conventional in this field. Furthermore, when using such amounts, the fractional occupancy of antibody binding sites by analyte is independent of both sample volume and antibody concentration. Labelling of both the sensor-antibody and a developing antibody (designed to recognize either occupied or unoccupied sensor-antibody binding sites) permits the development of "ratiometric" immunoassays relying on measurement of the ratio of signals emitted by the two labelled antibodies. Furthermore, the sensor-antibody can be located within a "microspot" a few microns 2 in area. By labelling both sensor and developing antibodies with fluorescent labels, and scanning the microspot using a highly focussed laser beam, microspot immunoassays at least comparable in sensitivity with conventional "macroscopic" immunoassays are made possible. This in turn permits the development of immunoassay "arrays" capable in principle of measuring very large numbers of different substances within small samples (such as a drop of blood). The general principles and theory underlying these concepts are discussed, and preliminary experimental data using currently available instrumentation reported.

Mesh:

Year:  1990        PMID: 2099119

Source DB:  PubMed          Journal:  Ann Biol Clin (Paris)        ISSN: 0003-3898            Impact factor:   0.459


  15 in total

1.  PNA microarrays for hybridisation of unlabelled DNA samples.

Authors:  Ole Brandt; Julia Feldner; Achim Stephan; Markus Schröder; Martina Schnölzer; Heinrich F Arlinghaus; Jörg D Hoheisel; Anette Jacob
Journal:  Nucleic Acids Res       Date:  2003-10-01       Impact factor: 16.971

Review 2.  [Microarray technique for component resolved diagnosis (CRD) in type-I allergies. An innovative technology at the border between research tool and routine diagnostics].

Authors:  L Klimek; D Vetter; L von Bernus; C Thorn
Journal:  HNO       Date:  2011-10       Impact factor: 1.284

3.  A protein microarray immunoassay for the serological evaluation of the antibody response in vertically transmitted infections.

Authors:  A Ardizzoni; B Capuccini; M C Baschieri; C F Orsi; F Rumpianesi; S Peppoloni; C Cermelli; M Meacci; A Crisanti; P Steensgaard; E Blasi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-05-05       Impact factor: 3.267

4.  The 10th Anniversary of Carbohydrate Microarrays (2002-2012).

Authors:  Denong Wang; Nathan Collins
Journal:  J Proteomics Bioinform       Date:  2013-01-28

5.  Strong and oriented immobilization of single domain antibodies from crude bacterial lysates for high-throughput compatible cost-effective antibody array generation.

Authors:  Klervi Even-Desrumeaux; Daniel Baty; Patrick Chames
Journal:  Mol Biosyst       Date:  2010-09-21

6.  Empirically optimized flow cytometric immunoassay validates ambient analyte theory.

Authors:  Zaheer A Parpia; David M Kelso
Journal:  Anal Biochem       Date:  2010-02-10       Impact factor: 3.365

7.  Spot tests: past and present.

Authors:  María Teresa Doménech-Carbó; Antonio Doménech-Carbó
Journal:  ChemTexts       Date:  2021-12-27

8.  Profiling receptor tyrosine kinase activation by using Ab microarrays.

Authors:  Ulrik B Nielsen; Mike H Cardone; Anthony J Sinskey; Gavin MacBeath; Peter K Sorger
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-22       Impact factor: 11.205

Review 9.  Auditory proteomics: methods, accomplishments and challenges.

Authors:  Samson Jamesdaniel; Richard Salvi; Donald Coling
Journal:  Brain Res       Date:  2009-02-24       Impact factor: 3.252

10.  Analyzing stochastic transcription to elucidate the nucleoid's organization.

Authors:  Alessandra Riva; Anne-Sophie Carpentier; Frédérique Barloy-Hubler; Angélique Chéron; Alain Hénaut
Journal:  BMC Genomics       Date:  2008-03-10       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.